{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-064745","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.109013+00:00","generated_at":"2026-05-22T09:02:31.394412+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LifeStance Q1 revenue $333M (+11%), first positive net income as public company","bullets":["Revenue $333M (+11% YoY); net income $0.7M vs net loss $21.1M in Q1 2024.","Adjusted EBITDA $34.6M (+25% YoY); Center Margin $109.8M (33.0% of revenue).","Clinician base grew to 7,535 (+10% YoY); visit volumes 2.1M (+10%).","FY 2025 guidance reaffirmed: revenue $1.40B-$1.44B, Adj EBITDA $130M-$150M.","Q2 2025 guidance: revenue $332M-$352M, Adj EBITDA $28M-$34M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-064745","json":"https://secwatch.observer/filing/0000950170-25-064745.json","markdown":"https://secwatch.observer/filing/0000950170-25-064745.md","text":"https://secwatch.observer/filing/0000950170-25-064745.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000095017025064745/0000950170-25-064745-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000095017025064745/lfst-20250507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T09:02:31.394412+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}